Fish oil supplementation enhanced CPT-11 (irinotecan) efficacy against MCF7 breast carcinoma xenografts and ameliorated intestinal side-effects.
about
Role of lipid peroxidation and antioxidant enzymes in omega 3 fatty acids induced suppression of breast cancer xenograft growth in mice.Dietary omega-3 fatty acids and ionizing irradiation on human breast cancer xenograft growth and angiogenesisDiet composition as a source of variation in experimental animal models of cancer cachexiaCancer stem/progenitor cell active compound 8-quinolinol in combination with paclitaxel achieves an improved cure of breast cancer in the mouse modelDocosahexaenoic acid induces apoptosis in MCF-7 cells in vitro and in vivo via reactive oxygen species formation and caspase 8 activationProtective role of fish oil (Maxepa) on early events of rat mammary carcinogenesis by modulation of DNA-protein crosslinks, cell proliferation and p53 expression.NF-kappaB pathway inhibitors preferentially inhibit breast cancer stem-like cellsOptical imaging of tumor cells in hollow fibers: evaluation of the antitumor activities of anticancer drugs and target validationCurrent clinical applications of omega-6 and omega-3 fatty acids.Consumption of an omega-3 fatty acids product, INCELL AAFA, reduced side-effects of CPT-11 (irinotecan) in miceLectin microarrays identify cell-specific and functionally significant cell surface glycan markers.n-3 Polyunsaturated fatty acids throughout the cancer trajectory: influence on disease incidence, progression, response to therapy and cancer-associated cachexia.Improving outcome of chemotherapy of metastatic breast cancer by docosahexaenoic acid: a phase II trial.Enhancing cytotoxic therapies for breast and prostate cancers with polyunsaturated fatty acids.HuangQin Decoction Attenuates CPT-11-Induced Gastrointestinal Toxicity by Regulating Bile Acids Metabolism Homeostasis.Therapeutic targeting of CPT-11 induced diarrhea: a case for prophylaxis.Nutrition modulation of gastrointestinal toxicity related to cancer chemotherapy: from preclinical findings to clinical strategy.How plausible is the use of dietary n-3 PUFA in the adjuvant therapy of cancer?Chemotherapy-induced gastrointestinal toxicity is associated with changes in serum and urine metabolome and fecal microbiota in male Sprague-Dawley rats.Effects of caloric intake on intestinal mucosal morphology and immune cells in rats treated with 5-FluorouracilSuppression of implanted MDA-MB 231 human breast cancer growth in nude mice by dietary walnut.Inhibition of nuclear factor kappa B activation in early-stage chronic lymphocytic leukemia by omega-3 fatty acids.Phospholipid fatty acid composition and diamine oxidase activity of intestinal mucosa from rats treated with irinotecan hydrochloride (CPT-11) under vegetable oil-enriched diets: comparison between perilla oil and corn oil.ω-3 Long Chain Polyunsaturated Fatty Acids as Sensitizing Agents and Multidrug Resistance Revertants in Cancer Therapy.DHA effect on chemotherapy-induced body weight loss: an exploratory study in a rodent model of mammary tumors.Strain-specific probiotic (microbial cell preparation) and omega-3 fatty acid in modulating quality of life and inflammatory markers in colorectal cancer patients: A randomized controlled trial.Downregulation of ABCE1 via siRNA affects the sensitivity of A549 cells against chemotherapeutic agents.Supplementation with fish oil increases first-line chemotherapy efficacy in patients with advanced nonsmall cell lung cancer
P2860
Q24796081-CAC0B4DA-57B6-4083-A7C5-1707C6B2CFD0Q24802057-2426AA12-D1F6-4E8A-A217-F4EDFD181968Q26738879-CEB69094-2B3B-4F75-996C-4F4762BED0A5Q33338039-3DC9A69C-C7E6-43F0-9014-61310C05D1B3Q33565452-CB2C49DF-2DB1-41A5-8AD9-DE8A695C69DEQ35800836-0A52F6A6-7BFA-4F02-B831-76C1ABC0ED84Q35872462-C5BCB056-8F3E-46AE-96CC-F08810A6092FQ35945066-2D5006EB-2065-4253-961E-9D5807C23A27Q36548128-704E4389-DE01-4D2E-806E-583E73DED76EQ36623755-CE82C96B-B6EF-4967-86D3-EFB5A85A47EDQ37323215-6022CDBC-2CEB-4DDC-869B-AB6D3DBE0677Q37350075-51600A7A-7D1C-4A90-A709-6AFE325A3BE1Q37427057-AD7A4C07-38BB-42F6-86E7-0D5C58A8C450Q37722636-3B2C74E1-29A3-4EEF-A6E3-71B629B3E46AQ37727573-A7963C8D-5244-49BF-A24C-D529E6AB7DA3Q37731433-08B0BF47-4FE0-4EF4-A57F-BE75A4859125Q37827656-B6838888-98E2-4CE2-A044-346DC208D432Q39771420-606D4E33-BA85-4C2C-B64E-6E65A61DD7A3Q41160069-F2A96BA6-773B-4412-82CB-703BBE4D0D43Q41940852-C4A6D254-E537-446F-9AB5-A90AF173F645Q44941323-19E9CE29-4A94-4623-9450-8FE82D818449Q45290867-2B6E2D70-A33B-423A-BD7E-741615822C65Q46976059-699577E6-EB30-4E2A-822A-3D4F36497D1EQ47230140-8AE73A9B-2224-4E4F-9993-2C5A9C6FD133Q47280836-C5904BC8-70DD-4ED7-B390-E13DEBB46466Q47878304-9C0CD7DF-57C2-4B4F-AA9A-AD50E292F450Q51001472-E56E3FAB-B3E3-499F-A32D-4873CEAE9FF9Q57314892-55DAB8FA-BFF6-40C6-A24F-988A1AE41E7B
P2860
Fish oil supplementation enhanced CPT-11 (irinotecan) efficacy against MCF7 breast carcinoma xenografts and ameliorated intestinal side-effects.
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
1999年论文
@zh
1999年论文
@zh-cn
name
Fish oil supplementation enhan ...... rated intestinal side-effects.
@ast
Fish oil supplementation enhan ...... rated intestinal side-effects.
@en
type
label
Fish oil supplementation enhan ...... rated intestinal side-effects.
@ast
Fish oil supplementation enhan ...... rated intestinal side-effects.
@en
prefLabel
Fish oil supplementation enhan ...... rated intestinal side-effects.
@ast
Fish oil supplementation enhan ...... rated intestinal side-effects.
@en
P2093
P2860
P356
P1476
Fish oil supplementation enhan ...... rated intestinal side-effects.
@en
P2093
I L Cameron
W E Hardman
P2860
P2888
P304
P356
10.1038/SJ.BJC.6690713
P407
P577
1999-10-01T00:00:00Z
P5875
P6179
1052273098